Obesity may be treated by bariatric procedures and is related to enterohormone release
modulation. Nevertheless, a majority of commonly used surgical procedures have a …

Objective: To study the effect of bariatric surgery on the entero-hypothalamic endocrine axis
of humans and rodents. Background: Bariatric surgery is the most effective obesity treatment …

Background There are currently few pre-operative predictors of initial and long-term weight
loss following bariatric surgery. Objectives We evaluated the role of pre-operative patient …

Objective The aim of this study was to compare changes in gastrointestinal hormones and
appetite ratings after a similar weight loss induced by a very low‐energy diet alone or in …

BACKGROUND: We determined whether Roux-en-Y gastric bypass (RYGB)–induced
protracted weight loss is associated with an increase in anorectic peptide YY (PYY) and …

Background Roux-en-Y gastric bypass (RYGB) surgery is an effective and frequently used
surgical treatment for severe obesity. Postoperative weight loss varies markedly, but …

Background Bariatric surgery is the most effective treatment for achieving long-term weight
loss in morbidly obese patients. This study investigated prospective changes in gut …

Background Roux-en-Y gastric bypass (RYGB) produces greater weight loss compared with
a purely restrictive procedure such as laparoscopic adjustable gastric banding (LAGB) …

Background Altered enteroendocrine hormone responses are widely believed to underlie
the beneficial effects of bariatric surgery in type 2 diabetes. While elevated postprandial …

Objective: The objective of this study was to quantify hormones that regulate energy and
glucose homeostasis to establish possible mechanisms for the greater efficacy of Roux-en-Y …